What is INCR.TA's gross margin?

InterCure (INCR.TA) has a gross margin of 31% and a net margin of -1%.

What is INCR.TA's P/E ratio?

Track InterCure (INCR.TA) P/E ratio, ROE, and valuation metrics over time.

Where can I see INCR.TA's full financials?

See InterCure (INCR.TA) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

InterCure (INCR.TA) Financials — Revenue, Earnings, Cash Flow

Also trades as: INCR (NASDAQ) · $vol 0M

₪1,689.00 ($5.55)

+12.00 (+0.72%)

TLV · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 53 · ₪200.1M mcap · 8M float · 0.306% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

₪243M

Revenue

-10.8% YoY

₪-71M

Net Income

-8.1% YoY

₪-23M

Free Cash Flow

+33.1% YoY

30.9%

Gross Margin

4.4%

Op. Margin

-1.3%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-15.9%

ROA-9.5%

ROIC-10.2%

Valuation

P/E-4.8

P/B0.4

EV/EBITDA-5.3

Leverage

Debt/Equity0.42

Current Ratio1.85

Interest Cov.-10.4x

Quality Scores

Piotroski F2/9

Altman Z0.22

Beneish M-2.96